ELION THERAPEUTICS Trademark
Trademark Overview
On Wednesday, December 6, 2023, a trademark application was filed for ELION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELION THERAPEUTICS trademark a serial number of 98301402. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, July 5, 2024. This trademark is owned by Sfunga Therapeutics, Inc.. The ELION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:
Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease
General Information
| Serial Number | 98301402 |
| Word Mark | ELION THERAPEUTICS |
| Filing Date | Wednesday, December 6, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, July 5, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical research and development; Research and development of medications administered by a healthcare professional in a healthcare setting for systemic fungal infections or invasive fungal disease; Providing scientific information on the disease state and treatment of invasive fungal infections and invasive fungal disease; Providing a website featuring scientific information about the disease state and treatment of invasive fungal infections and invasive fungal disease |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 6, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, January 10, 2024 |
| First Use In Commerce Date | Wednesday, January 10, 2024 |
Trademark Owner History
| Party Name | ELION THERAPEUTICS, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | NEW YORK, NY 10010 |
| Party Name | Sfunga Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10010 |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 6, 2023 | NEW APPLICATION ENTERED |
| Sunday, March 3, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, May 16, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, May 23, 2024 | TEAS AMENDMENT OF USE RECEIVED |
| Thursday, May 23, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
| Thursday, May 23, 2024 | USE AMENDMENT FILED |
| Friday, July 5, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, July 5, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, July 5, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 5, 2024 | ASSIGNED TO EXAMINER |
| Friday, July 5, 2024 | USE AMENDMENT ACCEPTED |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, September 3, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
